Biotech

All Articles

Ideaya bags possibility on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...

Takeda takes $140M reduction on neglected epilepsy medication, promotes FDA manage

.Our company currently recognize that Takeda is intending to discover a pathway to the FDA for epile...

VBI Injections declare bankruptcy, seeks property purchase

.Immunology biotech VBI Vaccines is turning hazardously near the defining moment, along with program...

Celldex anti-cKIT antitoxin lower hives in one more period 2 research study

.It's hard to muscular tissue in on a room as reasonable as immunology, however Celldex Therapies th...

Boehringer offers up to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapeutics and a preclinical immune...

Ventyx's last resort for inflammatory med sides in Crohn's breakdown

.Ventyx Biosciences' Crohn's condition medicine performed not assist patients attain remission in a ...

Cognition's period 2 SHINE information blemish Alzheimer's possibility

.Knowledge Rehabs' period 2 sparkle trial has actually taken some of the gloss off the Alzheimer's d...

BMS centers bispecific months after submitting to work stage 3 test

.Bristol Myers Squibb has had a whiplash change of heart on its own BCMA bispecific T-cell engager, ...

Charles Baum manages Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., who oversaw Mirati Therapies' $ 5.8 billion purchase to Bristol Myers Sq...

Asarina to close after efforts to partner Tourette's medicine fall short

.After connecting to greater than 200 companies to partner a Tourette syndrome therapy that presente...